Please Wait.....
Report
Genital Warts (Condyloma Acuminatum)- Epidemiology Forecast-2032
Market Report I 2022-08-01 I 83 Pages I DelveInsight
DelveInsight's Genital Warts (Condyloma Acuminatum)- Epidemiology Forecast-2032' report delivers an in-depth understanding of the Genital Warts (Condyloma Acuminatum), historical and forecasted epidemiology as well as the Genital Warts (Condyloma Acuminatum) trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan, and China.
Genital Warts Disease Understanding
Genital warts (also known as anogenital warts, condylomata acuminata, condylomas) are benign proliferative lesions caused by human papillomavirus (HPV) types 6 and 11, which are found in >95% of lesions. Genital warts (GWs) are transmitted by having sexual contact with someone who already has them and may be found on the outside of genitals. Some types, which cause cancer, result in the growth of lesions on a woman's cervix. It is possible to get genital warts, HPV infection, even if they are not visible. Besides, they look like flesh-colored bumps that have a cauliflower-like appearance, and are usually flat, papular, or pedunculated growths on the genital mucosa, occurring in clusters.
GWs can appear on the penis, vulva, vagina, cervix, groin, or thigh within weeks or months after sexual contact with an infected person. Potentially cancer-causing HPV strains are spread by sexual intercourse, anal sex, and oral sex.
Genital Warts Diagnosis
Genital warts are often diagnosed by appearance. Sometimes a biopsy might be necessary based on indications such as atypical appearance, HIV positive persons, pigmented warts, poor response to the treatment and unclear diagnosis. Clinical diagnosis of GW is based on the appearance of warts, whereas histopathological diagnosis is not routinely indicated. Nucleic Acid Amplification Test for HPV DNA is also recommended. Accurate diagnosis is an essential first step in the treatment of GWs. They can be flat, dome-shaped, keratotic, pedunculated, and cauliflower-shaped; they may occur singularly, in clusters, or as plaques. Understanding the morphological presentation of these lesions is essential to accurate diagnosis of EGWs and their differentiation from other lesions that mimic them. However, warts are not exclusive to external genital tissues. Sexual exposure can be associated with warts in the urethra and at the meatus, cervix, vagina, anus, and oral cavity. Cervical warts, however, require clinicians to rule out high-grade dysplasia using Papanicolaou (Pap) tests before treatment.
Continued in the report..
Genital Warts Epidemiology Perspective by DelveInsight
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Incident cases of Genital Warts, Gender-specific Incident Cases of Genital Warts, Age-specific Incident Cases of Genital Warts, Anatomical Location of Genital Warts in Incident Population in the 7MM+China covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), Japan, and China from 2019 to 2032.
Genital Warts Detailed Epidemiology Segmentation
- In the assessment done by DelveInsight, the estimated total incident cases of GWs in the 7MM+China were 1,392,836 in 2021.
- The highest incident cases of GWs were accounted by the US in 2021 (545,316 cases), which are expected to show a rise in the future.
- Among the European countries, Germany had the highest incident population of GWs with 77,210 cases, followed by France, which had incident population of 55,798 in 2021. On the other hand, Spain had the lowest incident population (42,588 cases).
- Japan had 38,043 incident cases for GWs in 2021, accounting for approximately 3% in 7MM+China.
Scope of the Report
- The report covers the descriptive overview of Genital Warts, explaining its symptoms, grading, pathophysiology, and various diagnostic approaches.
- The report provides insight into the 7MM+China historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), Japan, and China.
- The report assesses the disease risk and burden of Genital Warts.
- The report helps to recognize the growth opportunities in the 7MM+China with respect to the patient population.
Report Highlights
- 11-Year Forecast of Genital Warts
- 7MM+China Coverage
- Incident Cases of Genital Warts
- Gender-specific Incident Cases of Genital Warts
- Age-specific Incident Cases of Genital Warts
- Anatomical Location of Genital Warts in Incident Population
Key Questions Answered
- What are the disease risk and burden of Genital Warts?
- What is the historical Genital Warts patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK), Japan and China?
- What would be the forecasted patient pool of Genital Warts at the 7MM+China level?
- What will be the growth opportunities across the 7MM+China with respect to the patient population pertaining to Genital Warts?
- Out of the above-mentioned countries, which country would have the highest incident population of Genital Warts during the forecast period (2022-2032)?
- At what CAGR the population is expected to grow across the 7MM+China during the forecast period (2022-2032)?
Reasons to buy
The Genital Warts report will allow the user to -
- Develop business strategies by understanding the trends shaping and driving the 7MM+China Genital Warts epidemiology forecast.
- The Genital Warts epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
- The Genital Warts epidemiology model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 11-year forecast period using reputable sources.
Key Assessments
- Patient Segmentation
- Patient Segmentation based on Gender
- Patient Segmentation based on Age
- Patient Segmentation based on Anatomical Location of Genital Warts
Geographies Covered
- The United States
- EU5 (Germany, France, Italy, Spain, and the United Kingdom)
- Japan
- China
Study Period: 2019-2032
1. Key Insights
2. Report Introduction
3. Genital Warts Epidemiology Overview at a Glance
3.1. Patient Share (%) Distribution of Genital Warts by Countries in 2019
3.2. Patient Share (%) Distribution of Genital Warts by Countries in 2032
4. Genital Warts Epidemiology: Future Perspective
5. Executive Summary of Genital Warts
6. Disease Background and Overview: Genital Warts
6.1. Introduction
6.2. Natural History
6.3. Causes and Risks
6.4. Symptoms
6.5. Pathophysiology
6.6. Clinical Presentation
6.7. Complications of Untreated HVP Infection
6.8. Diagnosis
6.8.1. Pap Test
6.8.2. HPV test
6.8.3. Newer Techniques
6.8.4. Diagnostic Guidelines
7. Treatment and Management
7.1. Chemical Treatment (Self-administered)
7.2. Chemical Treatment (Physician-applied)
7.3. Other Treatments
7.4. Ablative Treatment
7.5. Preventive Treatment
7.6. Therapies Not Recommended
7.6.1. Enhancing the Efficacy of Imiquimod
7.7. Adverse Effects of Treatment
7.8. Selection of Treatment
7.9. Special Management Issues
8. Vaccines
8.1. Gardasil: Merck
8.2. Cervarix: GlaxoSmithKline
8.3. Comparison
8.4. Differences
9. Guidelines
9.1. Anogenital Warts Treatment Guidelines: CDC
9.2. European Guideline for the Management of Anogenital Warts
9.3. Guidance on HPV vaccination in EU countries: Focus on boys, people living with HIV, and 9-valent HPV vaccine introduction: ECDC
9.4. Guidelines for the Management of Anogenital Warts in China
10. Epidemiology and Patient Population
10.1. Key Findings
10.2. Methodology of Epidemiology
10.3. Assumptions and Rationale: 7MM+China
10.3.1. United States
10.3.2. EU5 Countries
10.3.3. Japan
10.3.4. China
10.4. Total Incidence of GWs in the 7MM+China
10.5. The United States
10.5.1. Incident Cases of GWs in the United States
10.5.2. Gender Specific Incident Cases of GWs in the United States
10.5.3. Age Specific Incident Cases of GWs in the United States
10.5.4. Anatomical Location of GWs in Incident Population in the United States
10.6. Major Five European Countries
10.6.1. Incident cases of GWs in the EU-5
10.6.2. Gender Specific Incident Cases of GWs in the EU-5
10.6.3. Age Specific Incident Cases of GWs in the EU5
10.6.4. Anatomical Location of GWs in Incident Population in the EU-5
10.7. Japan
10.7.1. Incidence Cases of GWs in Japan
10.7.2. Gender Specific Incident Cases of GWs in Japan
10.7.3. Age Specific Incident Cases of GWs in Japan
10.7.4. Anatomical Location of GWs in Incidence Population in Japan
10.8. China
10.8.1. Incidence Cases of GWs in China
10.8.2. Gender Specific Incident Cases of GWs in China
10.8.3. Age Specific Incident Cases of GWs in China
10.8.4. Anatomical Location of GWs in Incident Population in China
11. Patient Journey
12. Appendix
12.1. Bibliography
12.2. List of Abbreviations
12.3. Report Methodology
13. DelveInsight Capabilities
14. Disclaimer
15. About DelveInsight
Table 1: Summary of Genital Warts Epidemiology (2019-2032)
Table 2: Low-risk HPV versus High-risk HPV
Table 3: Treatment Modalities
Table 4: Treatments and their Advantages
Table 5: Enhancing the efficacy of imiquimod
Table 6: Gardasil versus Cervarix
Table 7: Total Incident Population of GWs in 7MM+China (2019-2032)
Table 8: Incident cases of GWs in the United States (2019-2032)
Table 9: Gender Specific Diagnosed Cases of GWs in the United States (2019-2032)
Table 10: Age Specific Diagnosed Cases of GWs in the United States (2019-2032)
Table 11: Anatomical Location of GWs in Incident Population in the United States (2019-2032)
Table 12: Incident Cases of GWs in the EU-5 (2019-2032)
Table 13: Gender Specific Incident Cases of GWs in the EU-5 (2019-2032)
Table 14: Age Specific Incident Cases of GWs in the EU-5 (2019-2032)
Table 15: Age Specific Incident of GWs in Incident Population in the EU-5 (2019-2032)
Table 16: Incident Cases of GWs in Japan (2019-2032)
Table 17: Gender Specific Incident Cases of GWs in Japan (2019-2032)
Table 18: Age Specific Incident Cases of GWs in Japan (2019-2032)
Table 19: Anatomical Location of GWs in Incident Population in Japan (2019-2032)
Table 20: Incident Cases of GWs in China (2019-2032)
Table 21: Gender Specific Incident Cases of GWs in China (2019-2032)
Table 22: Age Specific Incident Cases of GWs in China (2019-2032)
Table 23: Anatomical Location of GWs in Incident Population in China (2019-2032)
Table 24: List of abbreviations
Figure 1: Different Types of Warts
Figure 2: HPV Structure and Function
Figure 3: HPV Structure and Function
Figure 4: Infection by HPV
Figure 5: Checklist for Initial Consultation
Figure 6: Checklist for providing Treatment
Figure 7: Treatment Algorithm
Figure 8: Newer Simplified Treatment Algorithm
Figure 9: Algorithm for Treatment Selection
Figure 10: Algorithm for Treatment Selection in Pregnant Patients
Figure 11: Total Incident Population of GWs in 7MM+China (2019-2032)
Figure 12: Incident cases of GWs in the United States (2019-2032)
Figure 13: Gender Specific Incident Cases of GWs in the United States (2019-2032)
Figure 14: Age Specific Incident Cases of GWs in the United States (2019-2032)
Figure 15: Anatomical Location of GWs in Incident Population in the United States (2019-2032)
Figure 16: Incident Cases of GWs in the EU-5 (2019-2032)
Figure 17: Gender Specific Incident Cases of GWs in the EU-5 (2019-2032)
Figure 18: Age Specific Incident Cases of GWs in the EU5 (2019-2032)
Figure 19: Anatomical Location of GWs in Incident Population in the EU5 (2019-2032)
Figure 20: Incident Cases of GWs in Japan (2019-2032)
Figure 21: Gender Specific Incident Cases of GWs in Japan (2019-2032)
Figure 22: Age Specific Incident Cases of GWs in Japan (2019-2032)
Figure 23: Anatomical Location of GWs in Incidence Population in Japan (2019-2032)
Figure 24: Incidence Cases of GWs in China (2019-2032)
Figure 25: Gender Specific Incident Cases of GWs in China (2019-2032)
Figure 26: Age Specific Incident Cases of GWs in China (2019-2032)
Figure 27: Anatomical Location of GWs in Incident Population in China (2019-2032)
Figure 28: Patient Journey
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security